Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Progress in Cardiovascular Diseases|March 1, 1996
A summary and assessment of the findings and conclusions of the ESVEM trialJ W Mason, F I Marcus, J T Bigger, et al.
Progress in Cardiovascular Diseases|March 1, 1996
Influence of Holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trialJ A Reiffel, M J Reiter, R A Freedman, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|April 1, 1987
Bronchodilator and other pharmacological activities of R-836 (2,5-diethyl-7-(4-thiomorpholino)-1,2,4-triazolo[1,5-c]pyrimidin e)K F Swingle, D M Hammerbeck, J R Schmid, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 1, 1995
Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609S J Gibson, L M Imbertson, T L Wagner, et al.
The American Journal of Cardiology|July 1, 1986
Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery diseaseA R Easley, D E Mann, M J Reiter, et al.
Pharmaceutical Development and Technology|February 23, 1999
Development of a topically active imiquimod formulationJ L Chollet, M J Jozwiakowski, K R Phares, et al.
Journal of Leukocyte Biology|September 1, 1995
Cytokine induction by the immunomodulators imiquimod and S-27609T L Testerman, J F Gerster, L M Imbertson, et al.
Cellular Immunology|September 28, 2000
Adjuvant activities of immune response modifier R-848: comparison with CpG ODNJ P Vasilakos, R M Smith, S J Gibson, et al.
Life Sciences|April 8, 1985
Comparison of anti-inflammatory compounds in the carrageenan induced paw edema model and the reversed passive Arthus model utilizing the same animalM J Reiter, D H Schwartzmiller, K F Swingle, et al.
The American Journal of Cardiology|April 1, 1982
The electrophysiologic basis and management of symptomatic recurrent tachycardia in patients with Ebstein's anomaly of the tricuspid valveW M Smith, J J Gallagher, C R Kerr, et al.
Pageof 17